First National Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,243
Closed -$207K 337
2018
Q2
$207K Sell
1,243
-203
-14% -$32.6K 0.02% 314
2018
Q1
$244K Sell
1,446
-842
-37% -$141K 0.03% 301
2017
Q4
$375K Sell
2,288
-493
-18% -$88.5K 0.04% 261
2017
Q3
$569K Buy
2,781
+420
+18% +$97.7K 0.07% 217
2017
Q2
$574K Buy
2,361
+218
+10% +$51.2K 0.07% 219
2017
Q1
$512K Sell
2,143
-257
-11% -$59.8K 0.07% 220
2016
Q4
$504K Sell
2,400
-1,266
-35% -$262K 0.07% 216
2016
Q3
$844K Sell
3,666
-2,265
-38% -$553K 0.13% 159
2016
Q2
$1.37M Sell
5,931
-1,301
-18% -$300K 0.21% 127
2016
Q1
$1.94M Sell
7,232
-465
-6% -$133K 0.3% 101
2015
Q4
$2.41M Sell
7,697
-370
-5% -$110K 0.38% 76
2015
Q3
$2.19M Buy
8,067
+409
+5% +$126K 0.38% 80
2015
Q2
$2.32M Buy
7,658
+1,933
+34% +$577K 0.37% 78
2015
Q1
$1.71M Buy
5,725
+1,213
+27% +$346K 0.29% 101
2014
Q4
$1.16M Buy
4,512
+1,838
+69% +$459K 0.21% 125
2014
Q3
$645K Buy
+2,674
New +$598K 0.12% 160

Other funds holding AGN

First National Trust's AGN Position: Q3 2018 in Review

First National Trust sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 1,243 shares — an estimated $207K sold.

First National Trust first reported a position in AGN in Q3 2014 and held it in 16 quarters. The position peaked at $2.41M in Q4 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • First National Trust reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • First National Trust sold 1,243 Allergan plc shares in Q3 2018, an estimated $207K.
  • First National Trust first reported a position in Allergan plc in Q3 2014 and held it in 16 quarters.
  • First National Trust's Allergan plc position peaked at $2.41M in Q4 2015.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on First National Trust's 13F filing for Q3 2018, filed 31 Oct 2018.